Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlucoTab MobileCare Basal-Insulin Workflow in Domiciliary Nursing Type 2 Diabetes
DRKS00015059Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin glargine and human insulin in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Graz. Primary endpoints: Acceptance of GlucoTab MobileCare, Usability of GlucoTab MobileCare and 2 more. Started Jul 2018; status: completed.
02
Drugs
insulin glarginehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on DRKS00015059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00015059.